肾上腺病变11例，其中良性肿瘤7例，恶性肿瘤2例，2例肾上腺增生症在随访观察中。
Of 11 cases adrenal diseases, there were 7 cases adrenal malignant tumor and 2 cases benign tumor, 2 cases adrenal hyperplasia.
羊水细胞DNA分析是先天性肾上腺皮质增生症21-羟化酶缺陷的产前诊断的可靠方法。
DNA analysis of amniocytes was a feasible method for the prenatal diagnosis of congenital adrenal hyperplasia with 21-hydroxylase deficiency.
目的提高对肾上腺髓质增生症(amh)的诊断与治疗水平。
Objective To study the diagnosis and treatment of adrenal medullary hyperplasia (AMH).
用放免法检测肾上腺皮质增生症患者血浆ACTH的浓度，并与肾上腺皮质组织中局部表达ACTH的水平进行相关性分析。
The correlation between plasma ACTH concentration and expression level of ACTH in adrenal cortical tissue of patients with adrenal cortical hyperplasia was studied.
目的探讨肾上腺皮、髓质增生症的诊断和治疗。
Objective To study the diagnosis and treatment of adrenal cortical and medullary hyperplasia.
目的开展新生儿先天性肾上腺皮质增生症筛查，降低残疾儿童的发生率，提高人口素质。
Objective to develop the neonatal screening for congenital adrenal hyperplasia in order to prevent children from congenital disability and improve the aristogenesis in our country.
结论羊水细胞DNA分析是先天性肾上腺皮质增生症2 1羟化酶缺陷的产前诊断的可靠方法。
Conclusion DNA analysis of amniocytes was a feasible method for the prenatal diagnosis of congenital adrenal hyperplasia with 21-hydroxylase deficiency.
结论羊水细胞DNA分析是先天性肾上腺皮质增生症2 1羟化酶缺陷的产前诊断的可靠方法。
Conclusion DNA analysis of amniocytes was a feasible method for the prenatal diagnosis of congenital adrenal hyperplasia with 21-hydroxylase deficiency.
应用推荐